An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Stopped The study was discontinued due to a change in development strategy and not due safety concern.
Conditions
Interventions
- DRUG: Sodium Cridanimod
- DRUG: progestin therapy
Sponsor
Xenetic Biosciences, Inc.